AVAILABILITY OF COST EFFECTIVENESS INFORMATION ON THE HIGHEST-COST DRUGS AND PROCEDURES IN THE UNITED STATES

被引：0
|
作者：
Bungay, K. [1 ]
Cohen, J. T. [2 ]
Chambers, J. [1 ]
Salem, M. [1 ]
Ciarametaro, M. [3 ]
Neumann, P. J. [1 ]
机构：
[1] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Ctr Evaluat Value & Risk Hlth, Boston, MA USA
[2] Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Boston, MA USA
[3] Natl Pharmaceut Council, Washington, DC USA
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1932
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP146
引用
收藏
页码：A282 / A282
页数：1
相关论文
共 50 条
  • [41] Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United States
    Wu, Jashin J.
    Feldman, Steven R.
    Rastogi, Shipra
    Menges, Brandy
    Lingohr-Smith, Melissa
    Lin, Jay
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 (08) : 769 - 774
  • [42] The Diminishing Cost-Effectiveness of the Newer Glucose-Lowering Drugs in the United States, 2010-2018
    Li, Piaopiao
    Patel, Rahul S.
    Vouri, Scott M.
    Shi, Lizheng
    Fonseca, Vivian
    Shao, Hui
    DIABETES, 2021, 70
  • [43] Characteristics of Cost-effectiveness Studies for Oncology Drugs Approved in the United States From 2015-2020
    Haslam, Alyson
    Lythgoe, Mark P.
    Akman, Emma Greenstreet
    Prasad, Vinay
    JAMA NETWORK OPEN, 2021, 4 (11)
  • [44] The High Cost of Prescription Drugs in the United States Origins and Prospects for Reform
    Kesselheim, Aaron S.
    Avorn, Jerry
    Sarpatwari, Ameet
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (08): : 858 - 871
  • [45] COST-EFFECTIVENESS OF BISPHOSPHONATES IN REDUCING HIP FRACTURES IN THE UNITED STATES
    Toliver, J.
    Blanchette, C. M.
    VALUE IN HEALTH, 2012, 15 (04) : A39 - A39
  • [46] The cost-effectiveness of a modestly effective HIV vaccine in the United States
    Long, Elisa F.
    Owens, Douglas K.
    VACCINE, 2011, 29 (36) : 6113 - 6124
  • [47] Bending the cost curve in the United States: the role of comparative effectiveness research
    Amir A Ghaferi
    Critical Care, 14
  • [48] Cost effectiveness of treatment of Parkinson's disease with entacapone in the United States
    Palmer, CS
    Nuijten, MJC
    Schmier, JK
    Subedi, P
    Snyder, EH
    PHARMACOECONOMICS, 2002, 20 (09) : 617 - 628
  • [49] Potential cost-effectiveness of public access defibrillation in the United States
    Nichol, G
    Hallstrom, AP
    Ornato, JP
    Riegel, B
    Stiell, IG
    Valenzuela, T
    Wells, GA
    White, RD
    Weisfeldt, ML
    CIRCULATION, 1998, 97 (13) : 1315 - 1320
  • [50] Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States
    Shepard, CW
    Ortega-Sanchez, IR
    Scott, RD
    Rosenstein, NE
    PEDIATRICS, 2005, 115 (05) : 1220 - 1232
12345